These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
306 related items for PubMed ID: 19810171
21. Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli. Hall WH, Opfer BJ, Gerding DN. Antimicrob Agents Chemother; 1980 Feb; 17(2):273-9. PubMed ID: 6247970 [Abstract] [Full Text] [Related]
24. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)]. Nasnas R, Gutmann L, Kitzis MD, Goldstein F, Acar JF. Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385 [Abstract] [Full Text] [Related]
25. Comparison of the in-vitro activities of ceftazidime and new cephalosporins against 107 strains of Pseudomonas aeruginosa and 249 strains of cefazolin-resistant Enterobacteriaceae. Thabaut A, Durosoir JL, Saliou P. J Antimicrob Chemother; 1981 Sep; 8 Suppl B():123-5. PubMed ID: 19810174 [Abstract] [Full Text] [Related]
27. The in-vitro activity of three anti-pseudomonal cephalosporins against isolates from patients with cystic fibrosis. Kelly N, Falkiner FR, Keane CT, Murphy M, Fitzgerald MX. J Antimicrob Chemother; 1981 Sep; 8 Suppl B():175-8. PubMed ID: 19802982 [Abstract] [Full Text] [Related]
28. The in vitro antibacterial activity of ceftriaxone in comparison with nine other antibiotics. Emmerson AM, Lamport PA, Reeves DS, Bywater MJ, Holt HA, Wise R, Andrews J, Hall MJ. Curr Med Res Opin; 1985 Sep; 9(7):480-93. PubMed ID: 3928265 [Abstract] [Full Text] [Related]
29. In-vitro activity of ceftazidime compared with other beta-lactam antibiotics. Clarke AM, Zemcov SJ. J Antimicrob Chemother; 1981 Sep; 8 Suppl B():57-62. PubMed ID: 19810169 [Abstract] [Full Text] [Related]
34. Susceptibility of gentamicin sensitive and resistant gram negative bacilli to ceftazidime. Bremner DA. Pathology; 1987 Jul; 19(3):274-6. PubMed ID: 3124067 [Abstract] [Full Text] [Related]
35. In vitro activity of ceftazidime and ceftriaxone. Keenholtz SL, Jacobus NV, Tally FP, Gorbach SL. Clin Ther; 1983 Jul; 5(6):603-16. PubMed ID: 6313195 [Abstract] [Full Text] [Related]
36. In vitro activity of ceftazidime, cefotaxime and piperacillin against multi-resistant gram-negative bacteria tested with a modified agar dilution method. Hoogkamp-Korstanje JA, Meijer CA. Eur J Clin Microbiol; 1982 Jun; 1(3):166-70. PubMed ID: 6293813 [Abstract] [Full Text] [Related]
37. [In vitro antibacterial activity of a new cephalosporin: cefpirome (HR 810). Comparison with ceftriaxone, cefotaxime, latamoxef and ceftazidime]. Le Noc P, Bryskier A, Le Noc D. Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):567-71. PubMed ID: 3534744 [Abstract] [Full Text] [Related]
38. Comparative in vitro activity of 8 cephalosporins on 109 strains of Neisseria gonorrhoeae and 60 strains of Neisseria meningitidis. Thabaut A, Durosoir JL, Saliou P. Chemotherapy; 1981 Jun; 27 Suppl 1():19-24. PubMed ID: 6265159 [Abstract] [Full Text] [Related]
39. Biological activity of BO-1236, a new antipseudomonal cephalosporin. Nakagawa S, Sanada M, Matsuda K, Hazumi N, Tanaka N. Antimicrob Agents Chemother; 1987 Jul; 31(7):1100-5. PubMed ID: 3116919 [Abstract] [Full Text] [Related]
40. The antimicrobial activity and beta-lactamase stability of cefpirome, a new fourth-generation cephalosporin in comparison with other agents. Cheng AF, Ling TK, Lam AW, Fung KS, Wise R. J Antimicrob Chemother; 1993 May; 31(5):699-709. PubMed ID: 8335498 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]